Abstract
To describe the real-world use of macitentan in pulmonary arterial hypertension (PAH) patients who switched from another ERA.
Full Text
Sign-in/Register to access full text options
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date